SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-021589
Filing Date
2024-02-13
Accepted
2024-02-13 17:09:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv01578-nurixtherapeuticsinc.htm SC 13G 11454
  Complete submission text file 0001104659-24-021589.txt   13104
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

IRS No.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Subject) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: SC 13G | Act: 34 | File No.: 005-91591 | Film No.: 24629081
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)